Suppression of experimental allergic encephalomyelitis by mitoxantrone

Susan C. Ridge, Adolph E. Sloboda, Richard A. McReynolds, Seymour Levine, Arnold L. Oronsky, S. S. Kerwar

Research output: Contribution to journalArticlepeer-review


Treatment of rats with a developing or an established lesion of experimental allergic encephalomyelitis (EAE) with mitoxantrone (Novantrone) suppressed the hind limb paralysis associated with the disease. Histopathological examination of the spinal cords of these rats showed that mitoxantrone-treated rats had reduced vascular lesions that are associated with EAE. Spleen cells derived from immunized rats that had been treated in vivo with mitoxantrone did not transfer disease when these cells were administered to naive syngenic recipients. In addition, spleen cells from diseased rats did not transfer EAE lesions when these cells were administered to recipients that had been treated with mitoxantrone. Recipients treated with mitoxantrone were resistant to EAE lesions induced by sensitized cells in a rapid passive transfer system. Finally, when spleen cells from rats with EAE were incubated, in vitro, with mitoxantrone, these cells did not transfer disease to recipients. Thus the present studies indicate that treatment with mitoxantrone can suppress the lesions associated with both the active and passive forms of EAE.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalClinical Immunology and Immunopathology
Issue number1
StatePublished - Apr 1985

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology


Dive into the research topics of 'Suppression of experimental allergic encephalomyelitis by mitoxantrone'. Together they form a unique fingerprint.

Cite this